The New Zealand Guidelines Group has produced two new papers related to autism. The first provides supplementary evidence-based guidance on the use of aripiprazole, citalopram and melatonin.
The second is a review of diagnostic instruments.
Both papers have been converted into electronic booklets and are available on the NZ ASD Guidelines website . A short version of the diagnostic instruments review is also available at this website.
No comments:
Post a Comment